|
FR1482844A
(fr)
*
|
1964-12-31 |
1967-06-02 |
Merck & Co Inc |
Procédé de préparation de nouveaux acides 2-[2-(phénylalkyl substitué)-3-indolyl] aliphatiques inférieurs
|
|
US3489767A
(en)
*
|
1966-01-12 |
1970-01-13 |
Sumitomo Chemical Co |
1-(phenylsulfonyl)-3-indolyl aliphatic acid derivatives
|
|
US3511841A
(en)
*
|
1967-05-29 |
1970-05-12 |
Sterling Drug Inc |
1-((4-,5-,6-,and 7-azaindolyl)-lower-alkyl)- 4-substituted-piperazines
|
|
US3557142A
(en)
*
|
1968-02-20 |
1971-01-19 |
Sterling Drug Inc |
4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
|
|
DE1926359A1
(de)
*
|
1968-05-24 |
1970-05-21 |
Acraf |
oxylkansaeuren
|
|
GB1573212A
(en)
*
|
1976-04-15 |
1980-08-20 |
Technicon Instr |
Immunoassay for gentamicin
|
|
DE3246932A1
(de)
*
|
1982-12-16 |
1984-06-20 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Substituierte 5h-pyrimido(5,4-b)indole
|
|
US4568649A
(en)
*
|
1983-02-22 |
1986-02-04 |
Immunex Corporation |
Immediate ligand detection assay
|
|
US4626513A
(en)
*
|
1983-11-10 |
1986-12-02 |
Massachusetts General Hospital |
Method and apparatus for ligand detection
|
|
ATE56096T1
(de)
|
1984-03-15 |
1990-09-15 |
Immunex Corp |
Test zur sofortigen feststellung von liganden, testsatz und seine herstellung.
|
|
US5688655A
(en)
*
|
1988-02-10 |
1997-11-18 |
Ict Pharmaceuticals, Inc. |
Method of screening for protein inhibitors and activators
|
|
GB9004301D0
(en)
|
1990-02-26 |
1990-04-18 |
Fujisawa Pharmaceutical Co |
Indolebutyric acid derivatives and process for preparation thereof
|
|
US5075313A
(en)
*
|
1990-09-13 |
1991-12-24 |
Eli Lilly And Company |
3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
|
|
EP0610793A1
(en)
*
|
1993-02-08 |
1994-08-17 |
Takeda Chemical Industries, Ltd. |
Tetracyclic morpholine derivatives and their use or analgesics
|
|
IL109309A
(en)
|
1993-04-16 |
2000-06-29 |
Lilly Co Eli |
1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
|
|
WO1994028028A1
(en)
*
|
1993-05-27 |
1994-12-08 |
Selectide Corporation |
Topologically segregated, encoded solid phase libraries
|
|
US5840485A
(en)
*
|
1993-05-27 |
1998-11-24 |
Selectide Corporation |
Topologically segregated, encoded solid phase libraries
|
|
US5763198A
(en)
*
|
1994-07-22 |
1998-06-09 |
Sugen, Inc. |
Screening assays for compounds
|
|
GB9416467D0
(en)
|
1994-08-13 |
1994-10-05 |
Wellcome Found |
Compounds for use in medicine
|
|
US5747276A
(en)
*
|
1995-09-15 |
1998-05-05 |
The Scripps Research Institute |
Screening methods for the identification of novel antibiotics
|
|
US6294330B1
(en)
*
|
1997-01-31 |
2001-09-25 |
Odyssey Pharmaceuticals Inc. |
Protein fragment complementation assays for the detection of biological or drug interactions
|
|
US6243980B1
(en)
*
|
1997-03-07 |
2001-06-12 |
Tropix, Inc. |
Protease inhibitor assay
|
|
US6178384B1
(en)
*
|
1997-09-29 |
2001-01-23 |
The Trustees Of Columbia University In The City Of New York |
Method and apparatus for selecting a molecule based on conformational free energy
|
|
JP5627160B2
(ja)
*
|
1998-02-23 |
2014-11-19 |
サウス、アラバマ、メディカル、サイエンス、ファウンデーションＳｏｕｔｈ Ａｌａｂａｍａ Ｍｅｄｉｃａｌ Ｓｃｉｅｎｃｅ Ｆｏｕｎｄａｔｉｏｎ |
医薬として用いるインドール−３−プロピオン酸、並びにそれらの塩およびエステル
|
|
AU5265599A
(en)
*
|
1998-04-08 |
1999-11-01 |
Takeda Chemical Industries Ltd. |
Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
|
|
DE19821002A1
(de)
*
|
1998-05-11 |
1999-11-18 |
Dresden Arzneimittel |
Neue 1,5- und 3-O-substituierte 1H-Indazole mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
AU4543899A
(en)
*
|
1998-06-08 |
1999-12-30 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
TNSN99224A1
(fr)
*
|
1998-12-01 |
2005-11-10 |
Inst For Pharm Discovery Inc |
Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
|
|
IL145922A0
(en)
*
|
1999-04-28 |
2002-07-25 |
Aventis Pharma Gmbh |
Di-aryl acid derivatives as ppar receptor ligands
|
|
PT1177176E
(pt)
|
1999-04-28 |
2006-08-31 |
Aventis Pharma Gmbh |
Derivados de acidos triarilicos como ligandos de receptores ppar.
|
|
DE60025621T2
(de)
|
1999-09-17 |
2006-11-23 |
Kyorin Pharmaceutical Co., Ltd. |
O-anisamid-derivate
|
|
FR2801585B1
(fr)
|
1999-11-25 |
2002-02-15 |
Fournier Ind & Sante |
Nouveaux antagonistes des recepteurs de l'ii-8
|
|
ATE407919T1
(de)
|
2000-05-29 |
2008-09-15 |
Kyorin Seiyaku Kk |
Substituierte phenylpropionsäure-derivate
|
|
US6713507B2
(en)
|
2000-10-11 |
2004-03-30 |
Esperion Therapeutics, Inc. |
Ether compounds and compositions for cholesterol management and related uses
|
|
KR100965201B1
(ko)
*
|
2001-06-12 |
2010-06-24 |
웰스테트 테라퓨틱스 코포레이션 |
대사 질환의 치료용 화합물
|
|
US6869975B2
(en)
*
|
2001-09-14 |
2005-03-22 |
Tularik Inc. |
Linked biaryl compounds
|
|
EP1501826B1
(en)
|
2002-02-01 |
2006-09-27 |
F. Hoffman-la Roche AG |
Substituted indoles as alpha-1 agonists
|
|
US6806265B2
(en)
*
|
2002-05-16 |
2004-10-19 |
Boehringer Ingelheim International Gmbh |
Non-nucleoside reverse transcriptase inhibitors
|
|
JPWO2004007439A1
(ja)
|
2002-07-10 |
2005-11-10 |
住友製薬株式会社 |
ビアリール誘導体
|
|
SE0202241D0
(sv)
|
2002-07-17 |
2002-07-17 |
Astrazeneca Ab |
Novel Compounds
|
|
NZ541234A
(en)
|
2002-12-20 |
2008-06-30 |
Amgen Inc |
Asthma and allergic inflammation modulators
|
|
AU2003287912A1
(en)
|
2002-12-20 |
2004-07-14 |
Novo Nordisk A/S |
Dicarboxylic acid derivatives as ppar-agonists
|
|
AU2003300131A1
(en)
|
2003-01-06 |
2004-11-04 |
Eli Lilly And Company |
Indole derivatives as ppar modulators
|
|
US7348338B2
(en)
*
|
2003-07-17 |
2008-03-25 |
Plexxikon, Inc. |
PPAR active compounds
|
|
KR101415503B1
(ko)
*
|
2003-07-17 |
2014-07-04 |
플렉시콘, 인코퍼레이티드 |
Ｐｐａｒ 활성 화합물
|
|
WO2005012221A1
(ja)
|
2003-08-04 |
2005-02-10 |
Ono Pharmaceutical Co., Ltd. |
ジフェニルエーテル化合物、その製造方法および用途
|
|
JP2007508382A
(ja)
|
2003-10-14 |
2007-04-05 |
イーライ リリー アンド カンパニー |
Ｐｐａｒモジュレータとしてのフェノキシエーテル誘導体
|
|
WO2005040112A1
(en)
|
2003-10-14 |
2005-05-06 |
Oxagen Limited |
Compounds with pgd2 antagonist activity
|
|
JP2007508363A
(ja)
|
2003-10-14 |
2007-04-05 |
オキサジェン リミテッド |
Ｃｒｔｈ２アンタゴニスト活性を有する化合物
|
|
GB2407318A
(en)
|
2003-10-23 |
2005-04-27 |
Oxagen Ltd |
Substituted Indol-3-yl acetic acid derivatives
|
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
|
CA2547212A1
(en)
|
2003-11-25 |
2005-06-16 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
RU2240793C1
(ru)
*
|
2003-12-02 |
2004-11-27 |
Лимонов Виктор Львович |
Противоопухолевое средство
|
|
EP1689389A4
(en)
|
2003-12-04 |
2009-06-17 |
Nat Health Research Institutes |
Indole compounds
|
|
US20050203151A1
(en)
|
2003-12-19 |
2005-09-15 |
Kalypsys, Inc. |
Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions
|
|
WO2005092131A1
(en)
|
2004-03-01 |
2005-10-06 |
Mirko Uzelac |
Bipartite butcher's handshalter with couple
|
|
GB0412914D0
(en)
|
2004-06-10 |
2004-07-14 |
Oxagen Ltd |
Compounds
|